Regulatory affairs
This entire item is of approximately 400 words
  • Click here to read this item in full online now
  • Click here to subscribe to Biomedical Materials and immediately access all its archives
  • Click here to review the contents of the November 2010 issue of Biomedical Materials and download it online

  • Issue: November 2010, page: 7

    US authority reneges on decision to clear Menaflex knee implant

    Following re-evaluation of certain evidence, the US Food and Drug Administration (FDA) has begun the process to rescind the marketing clearance it awarded in December 2008 to the Menaflex collagen scaffold for use in the knee.

    Read related items on:

          
  • Medical
  • Market reports
  • ReGen Biologics
  • US Food and Drug Administration

  • International Newsletters ©
     
                                                 Advertising on this site | Privacy Policy | Contact